Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry.

Saved in:
Bibliographic Details
Title: Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry.
Authors: Rossignol, Patrick1 (AUTHOR) p.rossignol@chru‐nancy.fr, Lainscak, Mitja2 (AUTHOR), Crespo‐Leiro, Maria G.3 (AUTHOR), Laroche, Cécile4 (AUTHOR), Piepoli, Massimo F.5 (AUTHOR), Filippatos, Gerasimos6 (AUTHOR), Rosano, Giuseppe M.C.7 (AUTHOR), Savarese, Gianluigi8 (AUTHOR), Anker, Stefan D.9 (AUTHOR), Seferovic, Petar M.10 (AUTHOR), Ruschitzka, Frank11 (AUTHOR), Coats, Andrew J.S.7 (AUTHOR), Mebazaa, Alexandre12 (AUTHOR), McDonagh, Theresa13 (AUTHOR), Sahuquillo, Ana14 (AUTHOR), Penco, Maria15 (AUTHOR), Maggioni, Aldo P.4,16 (AUTHOR), Lund, Lars H.17 (AUTHOR), Christopher Peter Gale, GB (AUTHOR), Branko Beleslin, RS (AUTHOR)
Source: European Journal of Heart Failure. Aug2020, Vol. 22 Issue 8, p1378-1389. 12p. 1 Chart, 5 Graphs.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:13889842
DOI:10.1002/ejhf.1793